Creator sentiment
50/100
● Bullish 25%● Neutral 50%● Bearish 25%
4 creators · 4 views · past 7 days
Updated November 10, 2026 (UTC)
The bull case
- +Investors are finding secular growth opportunities in pharma, with Eli Lilly specifically named.
The bear case
- −Trades at 65x free cash flow and 158x the last five years, requiring enormous future profit growth to justify the premium.
- −Even with GLP-1 drugs, justifying that premium seems a hard endeavor; forward PE of 39 is still pricey.
- −He is waiting much longer before considering it.
What StockTubers recently said
The Patient Investor NeutralNov 8
📹 Stock Market Crash Is Almost Over! (Here's Why)
Eli Lilly also fell as non-AI stocks joined the market decline.
Everything Money BearishNov 7
📹 Why The Nasdaq is Really Crashing in 2026 (Sell Now or Buy the Dip?)
Trades at 65x free cash flow and 158x the last five years, requiring enormous future profit growth to justify the premium. · Even with GLP-1 drugs, justifying that premium seems a hard endeavor; forward PE of 39 is still pricey. · He is waiting much longer before considering it.
The Compound BullishNov 6
📹 Why Americans Are So Angry About the Economy
Investors are finding secular growth opportunities in pharma, with Eli Lilly specifically named.
